Tango Therapeutics, Inc. earnings per share and revenue

TNGX earnings per share for the last quarter are -0.27 USD whereas the estimation was -0.37 USD which accounts for 26.37% surprise. Company revenue for the same period amounts to 11.61 M USD despite the estimated figure of 8.07 M USD. Estimated earnings per share for the next quarter are -0.34 USD, and revenue is expected to reach 8.21 M USD. Also watch annual changes over time to get a bigger picture of TNGX earnings per share and revenue dynamics.